Clinical Trial Update: Phenylbutyrate to Treat Children With Progressive or Recurrent Brain Tumors [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating phenylbutyrate in children with progressive or recurrent brain tumors has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Tumor

Drugs mentioned

• Phenylbutyrate (phenylbutyrate)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Brain Tumor | Phase 2 | Status: COMPLETED